The vitamin E derivative, a-tocopheryl acetate, is often included in formulations used in enteral nutrition. In this respect, we compared a-tocopherol and a-tocopheryl acetate absorption under 'maldigestion' conditions, such as occurring during enteral tube feeding, using differentially labeled RRR-[5,7-methyl-( H 3 ]-a-tocopheryl acetate allowing direct comparison between free and esterified forms. SUBJECTS/METHODS: The two derivatives were given together in a single dose to six volunteers directly into the jejunum using a double-balloon perfusion system. Perfusion lasted for 1 h, and the collected blood and effluent samples were analyzed by liquid chromatography-mass spectrometry. RESULTS: In the isolated 20-cm length of exposed jejunum, on average B6% of the two vitamin E forms were absorbed 41 h based on subtraction of effluent from influent. There was substantial difference in the absolute absorbed quantity between individuals, but no significant differences were observed in the absorption between the two labeled forms as assessed in the plasma.
INTRODUCTION
Natural vitamin E is a generic designation for a group of eight compounds (tocopherols and tocotrienols) synthesized by plants. 1, 2 The supplemented form of vitamin E is mostly its acetate ester including the racemic mixture of eight stereoisomers accounting for the three chiral centers at 2, 4 0 and 8 0 positions. Vitamin E is the major and most potent lipid-soluble antioxidant in vivo. [3] [4] [5] It acts as a radical scavenging antioxidant in lipoproteins and efficiently interrupts the chain propagation of lipid oxidation, thus protecting low-density lipoproteins from oxidation. 6 Vitamin E is also associated with lowered risk of coronary heart disease and atherosclerosis, 7, 8 and ischemic heart disease in cross-cultural epidemiology. 9 Details on physiology, bioavailability and potency of vitamin E are available in several excellent reviews. 4, 7, 8, 10, 11 The digestion of tocopherols and tocotrienols broadly follows that of lipids, that is, emulsification and incorporation into mixed micelles, which are transported via the unstirred water layer and taken up by the enterocytes, partly via active transport, especially in the proximal intestine. 12 In enterocytes, tocopherols are incorporated into chylomicrons and transported into the circulation via the lymphatic system. 7, 8 Many variables influence vitamin E absorption, and both bile acids and pancreatic juice are thought to be important for the absorption of vitamin E. This has been established in patients where secretion of either, or both, is severely diminished, as in cholestatic liver disease, cystic fibrosis or pancreatitis, where severe vitamin E malabsorption occurs. 7, 8 During enteral feeding of critically ill patients, nutrients are delivered directly into the small intestine, without the addition of normal digestive juices, leading to the possibility of malabsorption.
A simultaneous intake of fat improves vitamin E absorption as it stimulates bile flow and secretion of pancreatic enzymes (including lipase and esterases) to allow micelle formation. If a vitamin E supplement is taken with a low-fat meal, the absorption of the vitamin into the blood, and therefore its efficacy, is significantly reduced. 13 Absorption of vitamin E was minimal when taken with only a glass of water, with cereal and semi-skimmed milk, but significantly higher when taken with cereal and full-fat milk or cream, and higher still when taken with a meal of toast and butter. 13 Vitamin E intake is for most people far from optimal 14 and so many clinical studies investigate the bioavailability and metabolism of this micronutrient. isotope-labeled tocopherols are a popular means to follow the fate of orally administered vitamin E, as these can be readily distinguished from the endogenous vitamin E pool of the body by mass spectrometry-based methods. [15] [16] [17] On the other hand, the bioavailability and health benefits of various vitamin E constituents (free versus acetylated) under various suboptimal conditions (for example, malabsorption during tube feeding) are still not fully understood. 18, 19 The aim of this study was to compare the bioavailability of free and acetylated a-tocopherol under maldigestion conditions and to ascertain whether normal pancreatic function is necessary for its efficient absorption in healthy volunteers by applying a closed segment intestinal perfusion technique in vivo.
MATERIALS AND METHODS

Subjects, groups and centers
Healthy subjects were recruited at the Vall d'Hebron Hospital, Barcelona. Inclusion criteria were X18 years, male (to eliminate gender variations), body mas index 18-25 kg/m 2 , baseline serum vitamin E 6-21 mg/l, triglyceride 0.45-1.85 g/l and cholesterol 1.3-2.2 g/l. Exclusion criteria were food, latex or any other allergy related to the perfusion components, any chronic disease or major gastrointestinal surgery, bowel disorder or regular consumption of vitamin supplements. Acetylsalicylates, nonsteroidal anti-inflammatory drugs, b 2 -agonists, acetaminophen, antacids, anticholinergics, codeine or opioid derivatives were allowed for up to 3 days before the perfusion, whereas any other drug or supplement was prohibited from 2 weeks before the study; moderate alcohol or caffeine ingestion was allowed up to the last 72 h before the study.
Written informed consent was obtained from each participant, including acceptance of pre-and post-study diet and meal provided on the day of perfusion. Subject personal information was protected by anonymous code. Six participants were enrolled to complete the study. H 3 ]-a-tocopherol acetate; 98 atom%) obtained from Orphachem (ClermontFerrand, France) were used. The products were analyzed and certified for human consumption with a complete sample dossier and safety evaluation. The use of deuterium-labeled vitamin E and vitamin E acetate enables differentiation from endogenous/dietary vitamin E.
The composition of the base dispersion containing the vitamin E and vitamin E acetate is shown in Table 1 . Monoglyceride (Dimodan U/J, a commercial grade form of monolinolein), polyglycerol ester (0 80/D) and ascorbyl palmitate were purchased from DuPont/Danisco (Grindsted, Denmark). Lysophosphatidylcholine (Sunlecithin A1) was obtained from Tayio Kagaku (Yokkaichi, Japan). Na-caseinate was obtained from Emi (Luzern, Switzerland). The preparation commenced by mixing ascorbyl palmitate, polyglycerol ester 0 80/D and Dimodan U/J. Then, deuterated a-tocopherol and deuterated a-tocopherol acetate were added to the melted mixture to form the lipid mixture. Sunlecithin A-1 (lysophosphatidylcholine) and sodium caseinate were added into bottled water under magnetic agitation. The lipid mixture, preheated to 70 1C, was then added to the lysolecithin/sodium caseinate solution also preheated to 70 1C. The pre-dispersing treatment was done with an ultraturrax (Kinematica, Lucerne, Switzerland) for 4 min at position 5/10 then the emulsion was passed through a Rannie homogenizer (Kindler Maschinen, Zurich, Switzerland) in continuous mode for 5 min at 450 bars. The dispersions were then transferred into 100 ml Pyrex bottles under nitrogen to avoid oxidation during sterilization and storage. The cubosome dispersions were sterilized using a standard heat treatment of 30 min at 121 1C in an autoclave Systec V100 (Systec, Wettenberg, Germany).
The base buffer consisted of 10.8 mM KCl, 240 mM NaCl, 4 mM Na 2 HPO 4 , 20 mM glucose, 70 mM mannitol and 500 mg phenol red (nonabsorbable volume marker) dissolved in normal distilled water and pH adjusted to 7.4 with 0.5 M NaOH. The final perfusion solution was obtained by mixing the base buffer solution and a base dispersion in a 1:1 proportion. The mixing was assisted by an ultrasonication probe and agitation to optimize homogeneity of the product. The particles, present in the dispersion, had an inverted bicontinuous structure of the double diamond type (space group Pn-3 m). The structure was assessed by cryo-transmission electron microscopy and small angle X-ray scattering as reported previously. 20, 21 This structure corresponds to a good physical stability of the dispersion and, as shown by light scattering and optical microscopy, minimal (if any) particle aggregation between the mixing procedure and the perfusion event. In this final perfusion solution, the concentration was 166.7 mg/l vitamin E and 250 mg/l vitamin E acetate. As the perfusion was performed at a flow rate of 5 ml/min for 60 min, a total amount of 50 mg vitamin E and 75 mg vitamin E acetate was administered per treatment.
Perfusion system
An in vivo human jejunal perfusion, 22 extensively used by us 23, 24 was utilized. A similar perfusion setup has also been described and evaluated by several other groups. [25] [26] [27] [28] Briefly, it comprises a multi-channel catheter with two occluding latex balloons (or multiple segments with more balloons) placed at a variable distance (usually between 10 and 20 cm) apart from one another. Once the instrument is inserted, the balloons are inflated to create an isolated segment in the jejunum; a separate tube allows proximal aspiration. A nonabsorbable dye, phenol red, can be added as volume marker to correct for the water absorption/secretion and to ensure that there is no leakage to or from the segment. Effluent, blood and urine samples are collected to study the systemic bioavailability. As digestion is prevented, no enzymes are added and there is no biliary or pancreatic secretions, the in situ perfusion system enables the study of absorption processes excluding digestion and therefore resembles severe maldigestion conditions and tube feeding in clinical nutrition.
Treatment of subjects
The overall experimental design is shown in Figure 1 . The isolated jejunal segment was perfused at a rate of 5 ml/min using a calibrated volumetric pump (COMPAT Enteral Feeding Pump, Novartis Medical Nutrition, Minneapolis, MN, USA). Intestinal effluent was collected by gravity in icechilled and light-protected containers at 4 1C every 15 min, aliquoted in 5 ml samples, snap frozen and stored at À 80 1C. Collection of effluent throughout the equilibration period was every 5 min. A perfusion buffer without vitamin E (1:1 dilution of the base buffer with distilled water) was used during the equilibration and wash-out period. After washing the intestinal segment with the perfusion buffer for 30 min to eliminate the intestinal content and reach equilibrium, the main perfusion (60 min) with the final perfusion solution followed. This included a single, combined dose of 50 mg of vitamin E and 75 mg vitamin E acetate delivered with a flow rate of 5 ml/min. Then the segment was rinsed in a post-irrigation step with the perfusion buffer for another 30 min. The perfusate from this postirrigation step was also collected in 15-min fractions. In parallel to the perfusion, every 30 min, 3 Â 2 ml of the perfusion solution, that had not passed the catheter, was taken and frozen at À 80 1C. As a final step, to minimize absorption of distally leaked formulation after its mixing with the intestinal juice following balloon deflation, the whole gut was rinsed with 1 1l of osmotic solution (Solució n Evacuante Bohm, Lab Bohm, SA, Madrid, Spain) immediately after the final jejunal perfusion and before removal of the probe.
A venous catheter was placed in the forearm after successful tube insertion in the jejunum. Blood samples were collected in EDTA tubes (10-ml fractions) at time 0 (B1000 hours, beginning of perfusion), and at the following time points after beginning the perfusion: 1, 3, 5, 7, 9 and 11 h (first day), 24, 26, 28, 30, 32 , 34 h (second day) and 48, 56 h (third day). Vitamin E absorption K Nagy et al Samples obtained from the intervention were aliquoted and frozen immediately. Blood samples were collected into EDTA tubes, centrifuged for 10 min at 3000 g at 4 1C to extract the plasma, which was kept at À 80 1C. Sample analysis. Sample preparation, liquid chromatography and mass spectrometric analysis of the samples were performed as reported elsewhere. 29 Statistical evaluation. Blood and effluent data were standardized by the median influent value. Vitamin E and vitamin E acetate area under the curve, in blood and in effluent, were calculated on the standardized values and were corrected for baseline. Area under the curve values were calculated according to the trapezoidal rule. Taking into account the distribution, Wilcoxon signed-rank tests were performed. Statistical analyses were done with Statistical Analysis Systems software (version 9.1; SAS Institute, Cary, NC, USA). H 3 ]-a-tocopherol acetate into the jejunum was performed, and influent and effluent samples were analyzed by liquid chromatography-mass spectrometry. Mean data on all six subjects are shown in Figure 2 . As expected, the analyzed vitamin E concentrations in the influent samples are close to the expected perfused concentration. The samples were also analyzed for 2 H 3 -a-tocopherol. Although free 2 H 3 -a-tocopherol is not present in the perfusion solution (influent), only its acetylated form, 2 H 3 -a-tocopherol appeared in the effluent (Figure 3 ) demonstrating that the acetylated form of vitamin E is cleaved by wall-bound enzymes in the lumen of the small intestine.
RESULTS
Luminal disappearance of vitamin E
Plasma appearance of perfused vitamin E Both 2 H 3 -and 2 H 6 -a-tocopherol appeared in the plasma as a consequence of perfusion (Figure 4) . Appearance of labeled tocopherols originating from the perfusion started at 2-5 h and reached C max at B10 h. This is in accordance with the findings of Cheeseman et al. 30 who found similar kinetics of free and acetylated a-tocopherol but in the presence of pancreas and bile salts (that is, normal oral administration). From the T max onwards, both forms of tocopherol diminished slowly to 30-50% of C max at 56 h. This suggests that elimination/metabolism half-time of a-tocopherol from plasma is around 2 days, consistent with the literature on normally fed subjects [16] [17] [18] [19] 31 and on 14 C-labeled a-tocopherol. 32 These suggest that the applied self-assembly system, as described in the Materials and methods section, enables the absorption of vitamin E even in the absence of bile salts and pancreatic enzymes. The concentration of unlabeled a-tocopherol was in the range of 20-30 mmol/l for the six subjects. The averaged absolute levels of deuterated vitamin E were 1-2% of the endogenous, nonlabeled form. The latter appeared stable for all subjects along the duration of the study despite the restriction in the diet. Data from all volunteers are combined and shown in Table 2 . Statistical analysis shows that there is no difference between the absorption of the two forms of tocopherol ( 2 H 6 -2 H 3 -a-tocopherol estimated difference ¼ À 0.049; lower 95% confidence interval À 0.144, upper 95% confidence interval ¼ 0.045, P-value ¼ 0.156). Although Brisson et al. 33 have reported that in Caco-2 cells the absorption of free and acetylated vitamin E was similar, this study is the first to show this in humans in the absence of bile salts and pancreatic secretions.
DISCUSSION
We compared the amount of 2 H 3 -a-tocopherol appearing in plasma as a result of perfusing 2 H 3 -a-tocopherol acetate to published values after oral consumption of vitamin E. Taking C max as a basis for comparison, the absorbed amount of 2 H 3 -atocopherol originating from 2 H 3 -a-tocopherol acetate (averaged for all subjects) was 0.402 mM or 0.174 mg/l in our study. We observed substantial interindividual variation even in such a perfusion system where differences between individuals such as transit time and digestive secretions are eliminated. This compares with previously published values where an intake of 75 mg vitamin E acetate resulted in a plasma C max of 4 mM after oral intake with standard breakfast containing 30-40 g fat. 18, 19, 31 Based on this, vitamin E absorption via our perfusion model is B10% compared with absorption reported in the literature via normal, oral intake conditions. These values suggest efficient absorption in the closed segmental in vivo perfusion setup, as only 20 cm of the gut is available 41 h for absorption, whereas via oral intake thebuffers and assisting on experimental procedures. This work was funded by Nestec Ltd, Switzerland. 2 H 6 -a-tocopherol. The error bars represent analytical triplicates. In the case of this subject, the unlabeled a-tocopherol was 28 ( ± 2.5) mM along the time course of the study. Abbreviation: AUC, area under the curve.
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